References
- Flickinger JC, Carr BI, Lotze MT. Cancer of the liver. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997: 1087–97
- Van Damme P, Kane M, Meheus A, for the Viral Hepatitis Prevention Board. Integration of hepatitis B vaccination into national immunisation programmes. BMJ 1997; 314(7086): 1033–6
- Gross JB Jr. Clinician's guide to hepatitis C. Mayo Clin Proc 1998; 73(4): 355–60
- Dana F, Becherer PR, Bacon BR. Hepatits C virus: what recent studies can tell us. Postgrad Med 1994; 95(6): 121–30
- Akriviadis EA, Llovet JM, Efremidis SC, et al. Hepatocellular carcinoma. Brit J Surg 1998; 85(10): 1319–31
- Niederau C, Fischer R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1995; 313(20): 1256–62
- Sherlock S. Hepatic tumours. In: Diseases of the liver and biliary system. 8th ed. London: Blackwell Scientific, 1989: 585
- Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin 1998; 48(1): 6–29
- El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340(10): 745–50
- Taylor-Robinson SD, Foster GR, Arora S, et al. Increase in primary liver cancer in the UK, 1979–94. (Letter) Lancet 1997; 350(9085): 1142–3
- Deuffic S, Poynard T, Buffat L, et al. Trends in primary liver cancer. (Letter) Lancet 1998; 351(9097): 214–5
- Chang MH, Chen CJ, Lai MS, et al, for the Taiwan Childhood Hepatoma Study Group. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336(26): 1855–9
- Okuda K, Kondo Y. Primary carcinoma of the liver. In: Haubrich WS, Schaffner F, Berk JE, eds. Bockus gastroenterology. 5th ed. Philadelphia: Saunders, 1995: 2444–88
- Isselbacher KJ, Dienstag JL. Carcinomas of the liver. In: Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998: 579–80
- Izzo F, Cremona F, Delrio P, et al. Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein. Ann Surg Oncol 1999; 6(2): 178–85
- Chalasani N, Horlander JC Sr, Said A, et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 1999; 94(10): 2988–93
- Kanematsu M, Hoshi H, Murakami T, et al. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. Am J Roentgenol 1997; 169(6): 1507–15
- Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States: prognostic features, treatment outcome, and survival. Cancer 1996; 77(11): 2217–22
- Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334(11): 693–9
- Yamamoto J, Iwatsuki S, Kosuge T, et al. Should hepatomas be treated with hepatic resection or transplantation? Cancer 1999; 86(7): 1151–8
- Dienstag JL, Schiff ER, Wright TL, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999; 341(17): 1256–63
- Baffis V, Shrier I, Sherker AH, et al. Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection. Ann Intern Med 1999; 131(9): 696–701
- Izzo F, Cremona F, Ruffolo F, et al. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Ann Surg 1998; 227(4): 513–8
- Curley SA, Izzo F, Gallipoli A, et al. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular carcinoma. Ann Surg 1995; 222(3): 375–83